Fottner, C.; Sollfrank, S.; Ghiasi, M.; Adenaeuer, A.; Musholt, T.; Schad, A.; Miederer, M.; Schadmand-Fischer, S.; Weber, M.M.; Lackner, K.J.;
et al. Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis. Cancers 2022, 14, 1798.
https://doi.org/10.3390/cancers14071798
AMA Style
Fottner C, Sollfrank S, Ghiasi M, Adenaeuer A, Musholt T, Schad A, Miederer M, Schadmand-Fischer S, Weber MM, Lackner KJ,
et al. Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis. Cancers. 2022; 14(7):1798.
https://doi.org/10.3390/cancers14071798
Chicago/Turabian Style
Fottner, Christian, Stefanie Sollfrank, Mursal Ghiasi, Anke Adenaeuer, Thomas Musholt, Arno Schad, Matthias Miederer, Simin Schadmand-Fischer, Matthias M. Weber, Karl J. Lackner,
and et al. 2022. "Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis" Cancers 14, no. 7: 1798.
https://doi.org/10.3390/cancers14071798
APA Style
Fottner, C., Sollfrank, S., Ghiasi, M., Adenaeuer, A., Musholt, T., Schad, A., Miederer, M., Schadmand-Fischer, S., Weber, M. M., Lackner, K. J., & Rossmann, H.
(2022). Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis. Cancers, 14(7), 1798.
https://doi.org/10.3390/cancers14071798